CATI Neuroimaging

What CATI Neuroimaging does

CATI Neuroimaging is a French academic service platform founded in 2011 and formally designated as multi-institute service unit US52-UAR2031. It provides end-to-end neuroimaging management for multicenter clinical research studies, with primary activity in neurodegenerative and psychiatric disorders. The platform serves approximately 60 active studies across 100+ French centers and 30+ European centers, supported by a consortium of six founding institutions: APHP, CNRS, CEA, ICM (Paris Brain Institute), Inserm, and Sorbonne University.

The platform's core technology stack comprises MRI/PET/SPECT acquisition protocol standardization, systematic quality control pipelines, BIDS-compliant data management with GDPR-compliant pseudonymization, and a portfolio of preprocessing pipelines (SPM, FreeSurfer, VolBrain, Morphologist, WHASA, LesionBrain, TractSeg, AMICO) supplemented by in-house custom pipelines. CATI Collector, a secure HTTPS-based DICOM upload service built on NeurospinCloud (CEA NextCloud with two-factor authentication), provides the data ingestion layer. Phantom-based reconstruction harmonization (Hoffman, Jaszczak, Striatal) for PET/SPECT and dummy-run volunteer testing for MRI ensure cross-scanner and cross-manufacturer consistency. Two offices anchor operations: Paris Brain Institute (169 rue du Chevaleret, 75013 Paris) and Neurospin/CEA (Gif-sur-Yvette), employing ~20 staff including a Research Director, two Codirectors (Nuclear Medicine, Neuroradiology), and an Operational Manager.

CATI operates a managed-services revenue model with direct engagement of principal investigators and research institutions across study design through data analysis. Pricing is not publicly disclosed but positioned as "reasonable cost," consistent with its public-sector institutional funding model rather than a commercial SaaS or fee-per-scan model. Go-to-market is sales-led and research-network-driven, with visibility generated through peer-reviewed publications (Lancet Neurology, NEJM, Alzheimer's & Dementia), academic conference presence, and a professional website. The platform has no disclosed venture capital or private equity investment and no disclosed revenue figures.

Name

CATI Neuroimaging

Legal name

CATI Neuroimaging

Website

https://cati-neuroimaging.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

CATI Neuroimaging is a French academic service platform that standardizes MRI/PET/SPECT acquisition, quality control, and BIDS-compliant data management for multicentre clinical research studies across 100+ French and 30+ European centers.

Ownership category

akta.pro rank

Product category

Clinical Research Neuroimaging Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Imaging & Cardiac Safety Core Labs (ECOG/EEG/ECG) (HLAGAAAJ)

Keywords

• Multicentre neuroimaging services
• MRI acquisition standardization
• PET SPECT imaging harmonization
• Neuroimaging data management
• Clinical research imaging

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Academic Service Platform: CATI is a French academic service platform labeled as multi-institute service unit US52-UAR2031, supported by major French research institutions (APHP, CNRS, CEA, ICM, Inserm, Sorbonne University). Revenue generation model not explicitly disclosed but operates as a service platform providing neuroimaging management to research studies at reasonable cost.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

CATI is a French academic service platform (multi-institute service unit US52-UAR2031) that manages end-to-end multicentre neuroimaging for clinical research studies. It standardizes MRI, MRS, PET and SPECT acquisition protocols across sites, performs quality control, runs image processing pipelines (structural, diffusion, functional, nuclear), and provides secure, GDPR-compliant data collection and BIDS-formatted data sharing for research consortia.

Product overview

CATI Neuroimaging is a French academic service platform that provides a comprehensive suite of neuroimaging services for multicenter clinical research studies. The core offering centers on the CATI Collector web platform for secure data upload, combined with protocol standardization services, image processing pipelines (structural, diffusion, functional, and nuclear imaging), and secure data sharing capabilities. The platform manages the full imaging workflow from protocol design through data acquisition, quality control, preprocessing, and BIDS-compliant data sharing, supporting MRI, PET, and SPECT modalities across over 100 French centers and 30+ European centers.

Differentiator

Problem solved

Functional benefit

Products and services

• CATI Collector

Quantifiable outcome

• ~60 multicentre neuroimaging studies supported with consistent quality standards across all participating centres
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• APHP (Assistance Publique - Hôpitaux de Paris)coreStrategic or Co-development Partner · 1 January 2011Major French hospital system and founding institution supporting CATI as a national platform for multicentre neuroimaging research.
• CNRS (Centre National de la Recherche Scientifique)coreStrategic or Co-development Partner · 1 January 2011Primary French national research agency and founding institution providing institutional support for CATI's neuroimaging service platform.
• CEA (Commissariat à l'énergie atomique et aux énergies alternatives)coreStrategic or Co-development Partner · 1 January 2011French Alternative Energies and Atomic Energy Commission, host of Neurospin facility where CATI operates, providing infrastructure and technical expertise.
• ICM (Paris Brain Institute / Institut du Cerveau et de la Moelle épinière)coreStrategic or Co-development Partner · 1 January 2011Paris Brain Institute hosting CATI headquarters, providing neuroimaging research environment and clinical collaboration.
• Inserm (Institut national de la santé et de la recherche médicale)coreStrategic or Co-development Partner · 1 January 2011French National Institute of Health and Medical Research and founding institution supporting CATI's academic service platform.
• Sorbonne UniversitycoreStrategic or Co-development Partner · 1 January 2011Major French university and founding institution providing academic affiliation and research collaboration for CATI.
• REMI NetworksupportingTechnology or IntegrationREMI (Réseau d'Expertise en Imagerie) network providing additional MRI physics and nuclear medicine expertise for protocol optimization and harmonization, referenced as a collaboration network for specific needs.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Others

• ENIGMA Consortium: Global academic consortium running large-scale meta-analyses of neuroimaging data across hundreds of sites. Conceptually similar to CATI's mission of pooling harmonised multicentre brain imaging data, though focused on retrospective pooling rather than prospective trial delivery.
• Alzheimer's Disease Neuroimaging Initiative (ADNI): Large public-private longitudinal neuroimaging consortium focused on Alzheimer's disease. Comparable to CATI in standardising multicentre MRI/PET acquisition and providing big-data dementia imaging resources, but operates as a research initiative rather than a service platform.

Emerging players

• Qynapse: French AI-driven neuroimaging company focused on CNS clinical trial endpoints. Geographically co-located with CATI and competes for French and European neurology trial imaging work with a commercial AI-automation angle.

Direct peers

• IXICO: UK-based imaging analytics CRO providing multicentre MRI analysis and imaging biomarker services for clinical trials in neurological disorders. Closely comparable to CATI in serving neuroimaging endpoints in neurodegenerative and psychiatric trials.
• VirtualScopics: Imaging core lab historically focused on quantitative imaging analysis for multicentre oncology and neurology clinical trials. Comparable to CATI's image processing and biomarker quantification services for clinical research.
• Invicro: Imaging CRO offering PET, SPECT, and MRI services for clinical research with strong focus on neurology and psychiatry trials. Comparable to CATI as a multicentre neuroimaging core lab supporting pharma-sponsored studies.

Broad incumbents

• Medpace: Mid-sized global CRO with imaging capabilities embedded in its full-service trial offerings. Competes for pharma-sponsored multicentre neuroimaging studies with a commercial, mid-tier CRO model.
• ICON plc: Global CRO with significant medical imaging services for clinical trials. Competes for the same multicentre neuroimaging studies CATI supports, though at broader scale across therapeutic areas.
• Clario (formerly Bioclinica): Large clinical trial technology and services company with imaging core lab capabilities (post BioClinica merger). Overlaps with CATI on multicentre imaging endpoint management but operates at global commercial scale across all therapeutic areas.

Regional players

• Cerveau Technologies: Provider of PET imaging agents and supporting services for neurodegenerative disease research, with strong US presence. Operates adjacently to CATI in the tau and amyloid PET trial supply chain serving the same pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cati-neuroimaging
• Xx.com/catineuro

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CATI Neuroimaging